Inspectors found ICU Medical made multiple changes to infusion pumps without submitting premarket notifications.

Oral semaglutide (Rybelsus) can be tied to a near halving of incident Afib, according to a meta-analysis of 26 randomized ...

A team led by Children's Hospital Los Angeles has become the first in the world to demonstrate the possibility of using ...

A team led by Children's Hospital Los Angeles (CHLA) has become the first in the world to demonstrate the possibility of ...

The US Food and Drug Administration (FDA) has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for ...

At today's Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) in ...

This marks the latest recall-related issue for HeartMate in recent years. Last June, the FDA deemed another recall as serious ...

A former college track athlete and mother of five hopes her story might save lives and inspire others to listen to their ...

CorWave said the results mark the final stage of CorWave’s preclinical development, paving the way for a first-in-human study ...

CorWave, a medical device company dedicated to the fight against heart failure, announces new preclinical results of its implantable heart pump. CorWave's in vivo studies demonstrated the pump's ...

When heart muscle gets damaged, the result is often permanent. Unlike other muscles in the body, the heart has long been ...